| Mikayla Niemoth, | |
|
3001 Spring Blvd, Bellevue, NE 68123-2665 | |
| (402) 293-5070 | |
| Not Available |
| Full Name | Mikayla Niemoth |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3001 Spring Blvd, Bellevue, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275216582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mikayla Niemoth, 2600 Arboretum Dr, Bellevue, NE 68005-3501 Ph: (402) 293-4000 | Mikayla Niemoth, 3001 Spring Blvd, Bellevue, NE 68123-2665 Ph: (402) 293-5070 |
News Archive
New Dental Choice, a comprehensive and affordable discount dental plan provided by First Dental Health, is now available nationwide. In addition, the plan now offers its members access to discount vision, hearing and prescription drug programs.
The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina.
Increased orthopaedic surgical procedures and an ageing baby boomer generation have been boosting the demand for bone grafts. Even as new applications and innovative products create exciting growth opportunities, the key challenge for bone graft substitutes suppliers is to produce material with clinical efficacy equivalent to, or surpassing, existing alternatives.
Cannabis Science, Inc., a pioneering US pharmaceutical cannabis company, notes that comments by President Obama's Deputy Director of the White House Office of National Drug Control Policy, Tom McClellan, in yesterday's USA TODAY pinpoints the need for non-smoked medical cannabis products similar to those currently being developed for FDA clinical trials by Cannabis Science.
Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.
› Verified 4 days ago
Paula Pouliot, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Spring Blvd, Bellevue, NE 68123 Phone: 402-293-5070 | |
Amy Schram, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12001 Timberridge Dr, Bellevue, NE 68133 Phone: 402-827-1850 | |
Ms. Malynda Carlene Mulvany, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2202 Washington St, Bellevue, NE 68005 Phone: 402-293-4938 Fax: 402-293-4351 | |
Jillian Kahl, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Dr Ste 208, Bellevue, NE 68005 Phone: 712-308-8233 Fax: 888-975-0225 | |
Barbara Fisher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13204 S 29th St, Bellevue, NE 68123 Phone: 402-293-4880 Fax: 402-293-5716 | |
Carol Eckstom, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12501 S 25th St, Bellevue, NE 68123 Phone: 402-293-4710 | |
Jessica Schram, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2726 Kennedy Blvd, Bellevue, NE 68123 Phone: 402-293-4760 |